It inhibits proliferation of breast cancer cells and tumor growth in mouse model. Beta lactamase linked affinity reagents based on cancer cell fusion peptides can be used directly in targeted enzyme prodrug development in cancer. This evidence concerns the gene LACTB and breast carcinoma.